Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
74°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by AngioDynamics, Inc.
AngioDynamics to Participate in Upcoming Investor Conferences
July 29, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics Reports Fiscal Year 2024 Fourth Quarter and Full-Year Financial Results
July 16, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics to Report Fiscal 2024 Fourth Quarter and Full-Year Financial Results on July 16, 2024
July 08, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics Announces CE Mark Approval in Europe for AlphaVac F18⁸⁵ System
May 21, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics’ APEX-AV Trial Results Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific Sessions
May 06, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture
April 04, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PE
April 04, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.
April 01, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics to Report Fiscal 2024 Third Quarter Financial Results on April 4, 2024
March 19, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics to Participate in a Fireside Chat at the Oppenheimer Virtual Healthcare MedTech & Services Conference
March 06, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 Million
February 15, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics Announces FDA 510(k) Clearance of Auryon XL Radial Access Catheter to Treat Peripheral Arterial Disease
January 23, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics Reports Fiscal Year 2024 Second Quarter Financial Results; Revises Fiscal Year 2024 Guidance
January 05, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics to Present at the J.P. Morgan Healthcare Conference
December 21, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics to Report Fiscal 2024 Second Quarter Financial Results on January 5, 2024
December 07, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F1885 System in Treatment of Pulmonary Embolism
December 07, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics Reports Fiscal Year 2024 First Quarter Financial Results; Reaffirms Fiscal Year 2024 Guidance
October 04, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics to Report Fiscal 2024 First Quarter Financial Results on October 4, 2023
September 12, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics Receives FDA Breakthrough Device Designation for the AngioVac System for the Non-Surgical Removal of Right Heart Vegetation
August 15, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics Completes Enrollment for PRESERVE Clinical Study
August 03, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics to Participate in a Fireside Chat at the Canaccord Genuity Growth Conference
July 31, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics Announces Addition of Lorinda Burgess to Board of Directors
July 24, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics Reports Fiscal Year 2023 Fourth Quarter and Full-Year Financial Results; Issues Fiscal Year 2024 Guidance
July 12, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics to Report Fiscal 2023 Fourth Quarter and Full-Year Financial Results on July 12, 2023
June 20, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics Announces Sale of Dialysis Product Portfolio and BioSentry Product to Merit Medical Systems for $100 Million
June 08, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics to Present at the Needham Virtual Healthcare Conference
April 11, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics Reports Fiscal 2023 Third Quarter Financial Results; Revises Guidance
March 30, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics to Report Fiscal 2023 Third Quarter Financial Results on March 30, 2023
March 13, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics to Participate in Three Investor Conferences in March
February 28, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics Reports Fiscal 2023 Second Quarter Financial Results; Reaffirms Guidance
January 05, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.